Platelet lysate composition
DE202026104409U1Undetermined Publication Date: 2026-10-15AVENTACELL BIOMEDICAL CORP
0 Cites 0 Cited by
Patent Information
- Application Number
- DE202026104409
- Authority / Receiving Office
- DE · DE
- Patent Type
- Utility models
- Current Assignee / Owner
- Filing Date
- 2026-07-27
- Publication Date
- 2026-10-15
- Estimated Expiration
- 2036-07-31
Abstract
A platelet lysate composition comprising platelet lysate; fondaparinux; calcium chloride (CaCl2); platelet growth factor-BB (PDGF-BB); and transforming growth factor beta 1 (TGF-β1); wherein the composition is free of heparin.
Need to check novelty before this filing date? Find Prior Art